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Summary
PRINCIPLES: Cancer is disease of aging that dispropor-
tionately affects older adults and often results in consid-
erable public health consequences. This study evaluated
gender-age-specific cancer mortality risk factors in older
adults in Switzerland with attention to the most common
types of cancer.
METHODS: The population included all individuals ≥65
years old based on 1990/2000 censuses linked to mortality
records through end of 2008. Cancer mortality relative risk
was assessed by gender-age-specific all-cancer and cancer-
specific mortality hazard ratios (HR) with 95% confidence
intervals (CI) from adjusted Cox proportional hazards re-
gression models.
RESULTS: The risk profile of dying from cancer was sim-
ilar in older men and women across most socio-demo-
graphic characteristics: higher cancer mortality risk with
lower educational attainment (all-cancer men HR = 0.84
[95%CI 0.82, 0.85] tertiary, HR = 1.09 [95%CI 1.07, 1.10]
compulsory, women all-cancer HR = 0.95 [95%CI 0.92,
0.98] tertiary, HR = 1.03 [95%CI 1.02, 1.05] compulsory)
and unmarried marital status. Cancer mortality risk factors
varied less than hypothesised across older age-groups.
However, for outcomes and characteristics with age-spe-
cific variation the oldest (≥85 years) generally showed the
lower cancer mortality relative risk (except for non-Swiss
lung cancer risk).
CONCLUSION: These comprehensive epidemiological
results indicate that in Switzerland (like other developed
countries) age alone is not the only important cancer risk
factor and risk is not necessarily the same across older age-
groups; providing additional needed information about the
aging-cancer nexus. However, additional studies especially
with consideration of stage of disease, treatments received
and comorbidity are needed.
Key words: cancer; cancer epidemiology; cancer
mortality; cancer risk factors; cancer mortality risk
factors; older adults; risk factors
Introduction
The World Health Organization reports that cancer, second
(but only nearly) to cardiovascular disease, is the most im-
portant cause of morbidity (≥3 million new cases per year)
and mortality (20% of all deaths, approximately 1.7 million
cancer deaths per year) in Europe [1]. Over the past dec-
ades in developed countries, cancer incidence and mortal-
ity have consistently shown a greater burden in older (≥65
years) compared to younger adults [1–4].
Because cancer is a disease of aging, the interaction of age
and cancer is of growing importance as the world’s popu-
lation ages but of distinct concern for developed societies
(i.e., greater numbers aging in developing countries but lar-
ger proportion aging in developed countries). Over the last
century there have been remarkable changes in the deve-
loped world’s population. One hallmark of these changes is
the rapid expansion of the older population with simultan-
eously low fertility rates. In Switzerland, with one of the
developed world’s highest life expectancies (in 2009 wo-
men 84.4 and men 79.8 years) and lowest fertility rates,
the inevitable shift in the population age structure (≥65
years 17% in 2009, projected 28% by 2050) foreshadows
many public health challenges [5–8]. Although we can-
not truly anticipate the changes that rapid population aging
will bring, we can work to understand the epidemiologic
patterns of aging, cancer, where they intersect, and their
potential implications. Such understanding will provide a
framework to address age-specific disparities in research,
prevention, and treatment in the largest cancer population;
older adults [9]. This is essential because demographic
pressures assure the complex resource intensive manage-
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ment of cancer in older adults will be an increasingly bur-
densome problem for developed societies like Switzerland.
Age is the single most important risk factor for developing
cancer [10]. Yet other factors such as socio-demographic
and geo-cultural characteristics (seldom examined at the
individual level in population-based epidemiological re-
search) may also be related to cancer risk in older adults.
Cancer mortality in Switzerland (from registration and
mortality data) has been previously published but without
attention to older age-groups or socio-demographic and
geo-cultural factors [4, 11–15]. This study, a comprehens-
ive look at cancer mortality risk factors, is an important
step towards addressing this aging-cancer knowledge gap.
Our objective utilising the Swiss National Cohort (SNC)
Study, a census based national research platform, was to
evaluate gender-age-specific cancer mortality risk factors
in older adults in Switzerland with attention to the most
common types of cancer [16, 17].
Methods
Study population
Study design and methods of the Swiss National Cohort
Study (SNC) have been reported elsewhere [16, 17].
Briefly, using a set of available common key variables
(e.g., sex, date of birth, place of residence, marital status)
1990 and 2000 census records were probabilistically linked
to federal death or emigration records using the General-
ized Record Linkage System (GRLS) [16, 18, 19]. Particip-
ation in the Swiss census is mandatory. Therefore, enumer-
ation is virtually complete; 2000 census estimated coverage
98.6% [20, 21]. The current study population included all
persons ≥65 years recorded in a census linked to mortality
records through the end of 2008 (N = 2,253,378). For addi-
tional methods details see companion paper.
Analytic variables
All cancer and cancer-specific mortality
All-cause and cause-specific cancer deaths recorded on of-
ficial Swiss death certificates between 1 January 1991 and
31 December 2008 were included in these analyses. Death
certificates have been shown to be an accurate source of
assigning cancer deaths [22, 23]. All-cause cancer deaths
(N = 208,239) were coded as underlying cause of death
by International Classification of Diseases version 8 (be-
fore 1995) and 10 (after 1994), ICD-8 codes 140-209 and
ICD-10 codes C00-C97. Cause-specific cancer deaths in-
cluded: breast cancer (N = 16,733) ICD-8 codes 174-175
and ICD-10 codes C50; colorectal cancer (N = 24,582)
ICD-8 153-154 and ICD-10 C18-C21; lung cancer (N =
33,454) ICD-8 162 and ICD-10 C33-C34; prostate cancer
(N = 22,740) ICD-8 185 and ICD-10 C61.
Socio-demographic characteristics
All socio-demographic variables were measured using
variables from the census. Questionnaires (German,
French, Italian, English) and variable lists (German,
French) are available from the SNC website
www.swissnationalcohort.ch [16]. Specifically included in
these analyses were: sex; age at census (65–74, 75–84,
≥85, also ≥65 years); nationality (Swiss, non-Swiss); edu-
cational level (compulsory schooling or less, secondary
education, tertiary education, not known); marital status
(single, married, widowed, divorced); religion (Catholic,
Protestant, no denomination, other/undeclared); urbanisa-
tion (urban, suburban, rural); household type (lives alone,
two or more persons, institution); language region (Ger-
man, French, Italian).
Analytic strategy
Cancer mortality was calculated using person years (PY) at
risk; additional analytic details available in the companion
paper. At risk time began on 1 January 1991 or 5 Decem-
ber 2000 (census date) if ≥65 years at census date other-
wise on date of 65th birthday. It ended on (first occurrence
of) date of death, date of emigration from Switzerland, 4
December 2000 for persons identified only in 1990 census,
or 31 December 2008. Total at risk person-time (age 65-74,
75-84, ≥85 years respectively) was men 4,747,989 PY;
2,640,244 PY; 715,836 PY and women 5,826,815 PY;
4,211,652 PY; 1,769,929 PY. All unlinked death records
were assigned an appropriately chosen (matched for sex,
age within 1 year) census record to avoid underestimation
of absolute mortality rates [24]. Although it has been pre-
viously shown that adjusting for unlinked deaths does not
substantially change relative risks, we performed sensitiv-
ity analyses that verified differences were indeed negligible
(supplementary table 1) [24].
We calculated gender-age-specific all-cancer and cancer-
specific mortality hazard ratios (HR) with 95% confidence
intervals using Cox proportional hazards regression models
and incidence rate ratios (IRR) with 95% CI using Poisson
regression models. Since results from both models were
nearly identical (supplementary table 2) we report only
HR. Models were adjusted for table 1 characteristics as-
sessing both gender-age-specific and gender-specific (com-
bined age ≥65 years) cancer mortality relative risk and in-
cluded an indicator variable for ICD coding period (before/
after ICD changes) and calendar year. All tabulated ana-
lyses were done using Stata version 11.1 [25].
Cancer mortality maps were plotted in ArcGIS using Pois-
son regression models with random effects to obtain
smoothed standardised mortality ratios (SMR) for each
community [26]. Estimates from small areas with zero or
few deaths were shrunk to the weighted mean of neigh-
bouring areas [27]. We obtained full Bayesian estimates of
the spatial variability using the conditional auto-regressive
distribution in WinBugs [28, 29].
Results
Due to the comprehensiveness of our analyses (number of
cancer sites, age categories, and independent variables) we
have included only the most important results. Full results
are available upon request from the authors. Because there
was little variation across older age-groups we primarily
present results from combined age (≥65 years) analyses.
Characteristics of the study population
The characteristics of the study population are listed in
table 1. Consistent with older adult populations, more wo-
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men than men were included. Approximately one-third
were age 65–74 years at census and nearly 40% turned
65 years old after census date. The population was over-
whelmingly Swiss (>90%), well educated (majority sec-
ondary or tertiary education), married (>60%), and lived
in a multi-person households (>65%). The population re-
flected expected Swiss language distributions, while only
one-quarter lived in rural communities. The population was
similar across gender, except (characteristically of older
populations) men were younger, more educated, and more
often married living in multi-person households.
Cancer mortality risk in older men
Table 2 lists the relative cancer mortality risk for older
Swiss men by socio-demographic and regional character-
istics. Cancer mortality risk decreased with increased edu-
cational attainment; all-cancer HR = 0.84 (95%CI 0.82,
0.85) tertiary, HR = 1.09 (95%CI 1.07, 1.10) ≤compulsory.
For older men being divorced or widowed was also related
to increased all-cancer, lung and colorectal cancer mortal-
ity risk; lung cancer HR = 1.17 (95%CI 1.11, 1.24) wid-
owed, HR = 1.41 (95%CI 1.33, 1.50) divorced. On the oth-
er hand, older men living in institutions and with other/
unknown religious affiliation had lower all-cancer and lung
cancer mortality risks than those in single or multi-person
households. We found that the association of cancer mor-
tality risk for older Swiss men varied by cancer type across
language regions. All-cancer and lung cancer mortality risk
was up to 10% lower in German-speaking areas yet pro-
state cancer mortality risk was reversed; prostate cancer
HR = 0.96 (95%CI 0.93, 0.99) French, HR = 0.84 (95%CI
0.78, 0.90) Italian. However, figure 1A shows modest dif-
ferences in SMR for older men not wholly by language re-
gion (Fribourg SMR = 107 and Lausanne SMR = 95 both
French-speaking).
Cancer mortality risk in older women
Relative all-cancer and cancer-specific mortality risks for
older Swiss women are shown in table 3. The risk profile
of dying from cancer in older women was similar to that
in older men across most socio-demographic characterist-
ics: higher cancer mortality risk with lower educational at-
tainment (all-cancer HR = 0.95 [95%CI 0.92, 0.98] tertiary,
HR = 1.03 [95%CI 1.02, 1.05] ≤compulsory) and unmar-
Table 1: Characteristics of the analytic study population (older Swiss adults ≥65 years old), 1991–2008.
Males Females
Total 986,634 (43.8%) 1,266,744 (56.2%)
Age at 1990 census
<65 years1
65–74 years
75–84 years
≥85 years
300,592 (30.5%)
231,609 (23.5%)
130,688 (13.2%)
28,774 (2.9%)
345,094 (27.2%)
296,476 (23.4%)
221,246 (17.5%)
74,971 (5.9%)
Age at 2000 census
<65 years1
65–74 years
75–84 years
≥85 years
281,521 (28.5%)
263,056 (26.7%)
146,993 (14.9%)
41,109 (4.2%)
302,211 (23.9%)
324,726 (25.6%)
234,578 (18.5%)
103,008 (8.1%)
Nationality
Swiss
Non-Swiss
869,840 (88.2%)
116,794 (11.8%)
1,169,358 (92.3%)
97,386 (7.7%)
Educational attainment
Compulsory schooling or less
Secondary education
Tertiary education
Not known
272,837 (27.7%)
483,990 (49.0%)
211,761 (21.5%)
18,046 (1.8%)
662,961 (52.3%)
501,777 (39.6%)
69,617 (5.5%)
32,389 (2.6%)
Marital status
Single
Married
Widowed
Divorced
76,507 (7.8%)
778,765 (78.9%)
73,345 (7.4%)
58,017 (5.9%)
136,867 (10.8%)
675,448 (53.3%)
361,231 (28.5%)
93,198 (7.4%)
Household type
Single person
Multi-person
Institution
135,712 (13.8%)
818,364 (82.9%)
32,558 (3.3%)
396,031 (31.3%)
790,671 (62.4%)
80,042 (6.3%)
Religion
Protestant
Roman Catholic
No denomination
Other / unknown
456,793 (46.3%)
412,358 (41.8%)
79,404 (8.0%)
38,079 (3.9%)
617,559 (48.8%)
539,006 (42.5%)
66,342 (5.2%)
43,837 (3.5%)
Language region
German
French
Italian
712,950 (72.3%)
226,029 (22.9%)
47,655 (4.8%)
907,334 (71.6%)
294,272 (23.2%)
65,138 (5.2%)
Urbanisation
Urban
Peri-urban
Rural
305,133 (30.9%)
419,611 (42.5%)
261,890 (26.6%)
443,788 (35.0%)
509,519 (40.2%)
313,437 (24.8%)
1 Study entry after census date on 65th birthday.
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ried marital status. Older women living in urban areas had
slightly higher all-cancer and cancer-specific mortality risk
A
B
Figure 1
A Map of Switzerland showing standardised cancer mortality ratios
for older Swiss men (≥65 years old).
B Map of Switzerland showing standardised cancer mortality ratios
for older Swiss women (≥65 years old).
© BFS. Reprinted with permission.
when compared to those living in peri-urban or rural areas
of Switzerland; all-cancer HR = 0.98 (95%CI 0.96, 0.99)
peri-urban, HR = 0.95 (95%CI 0.93, 0.99) rural. Despite
our findings of similar trends in absolute cancer mortality
trends in all language regions over the study period (see
companion publication) there were notable exceptions in
relative cancer-specific mortality risks. For example, older
women living in French- or Italian-speaking areas had al-
most 30% higher risk of lung cancer mortality while breast
cancer mortality risk by language region was reversed;
breast cancer HR = 0.92 (95%CI 0.89, 0.96) French, HR =
0.95 (95%CI 0.88, 1.02) Italian. Similar to older men SMR
(fig. 1B) indicated regional variation in all-cancer mortal-
ity risk but not consistently within language regions (e.g.,
Fribourg SMR = 108, Lausanne SMR = 96).
Gender-age-specific cancer mortality risk
The most important gender-age-specific relative all-cancer
and cancer-specific mortality risks are listed in table 4.
For both older men and women higher educational attain-
ment was related to decreased all-cancer mortality risk but
most pronounced in younger old persons; men 65–74 years
HR = 1.15 (95%CI 1.13, 1.18) ≤compulsory, HR = 0.77
(95%CI 0.75, 0.79) tertiary versus 74–84 years HR = 1.08
(95%CI 1.05, 1.10), HR = 0.87 (95%CI 0.85, 0.90) respect-
ively. Analogous to combined age analyses cancer mortal-
ity gender-age-specific cancer mortality risk also varied by
marital status, language region but also by age with less
variation in the oldest old. While non-Swiss oldest had
considerably higher lung cancer mortality risk than young-
er older foreign nationals; non-Swiss women HR = 0.77
(95%CI 0.68, 0.87) 65–74 years, HR = 1.07 (95%CI 0.92,
1.24) 75–84 years, HR = 1.30 (95%CI 1.01, 1.67) ≥85
years.
Table 2: Relative risks for cancer mortality in Swiss men ≥65 years old, 1991–2008.
Cancer mortality – HR (95% CI)Characteristic Category
All-cancer Lung cancer Colorectal cancer Prostate cancer
Nationality Swiss
Non-Swiss
1
0.98 (0.96, 1.00)
1
1.06 (1.01, 1.11)
1
1.00 (0.93, 1.08)
1
0.78 (0.73, 0.83)
Educational attainment Compulsory or less
Secondary education
Tertiary education
1.09 (1.07, 1.10)
1
0.84 (0.82, 0.85)
1.27 (1.24, 1.31)
1
0.65 (0.62, 0.67)
1.00 (0.96, 1.05)
1
0.88 (0.84, 0.92)
0.99 (0.96, 1.03)
1
0.95 (0.92, 0.99)
Marital status Single
Married
Widowed
Divorced
1.00 (0.97, 1.03)
1
1.10 (1.08, 1.13)
1.19 (1.16, 1.23)
0.91 (0.86, 0.96)
1
1.17 (1.11, 1.24)
1.41 (1.33, 1.50)
1.02 (0.94, 1.11)
1
1.09 (1.02, 1.17)
1.06 (0.96, 1.17)
0.90 (0.85, 0.96)
1
1.01 (0.96, 1.07)
0.98 (0.91, 1.07)
Household type Single person
Multi persons
Institutions
1.00 (0.97, 1.02)
1
0.95 (0.92, 0.98)
1.01 (0.96, 1.06)
1
0.82 (0.75, 0.89)
1.02 (0.95, 1.09)
1
0.95 (0.86, 1.05)
0.99 (0.94, 1.04)
1
0.99 (0.92, 1.06)
Religion Protestant
Roman Catholic
No affiliation
Other / unknown
1
1.04 (1.03, 1.05)
1.00 (0.98, 1.03)
0.90 (0.87, 0.93)
1
1.04 (1.01, 1.07)
1.05 (1.00, 1.11)
0.87 (0.81, 0.93)
1
1.04 (1.00, 1.08)
1.05 (0.97, 1.13)
0.96 (0.87, 1.05)
1
0.95 (0.92, 0.98)
0.89 (0.84, 0.95)
0.82 (0.76, 0.88)
Language region German
French
Italian
1
1.03 (1.02, 1.05)
1.08 (1.05, 1.11)
1
1.07 (1.04, 1.10)
1.10 (1.04, 1.16)
1
0.98 (0.94, 1.02)
1.01 (0.93, 1.10)
1
0.96 (0.93, 0.99)
0.84 (0.78, 0.90)
Urbanisation Urban
Peri-urban
Rural
1
0.96 (0.95, 0.98)
0.97 (0.95, 0.98)
1
0.92 (0.89, 0.94)
0.96 (0.93, 0.99)
1
0.99 (0.95, 1.04)
0.99 (0.95, 1.04)
1
1.01 (0.98, 1.04)
1.04 (0.98, 1.04)
CI =confidence interval; HR = Hazard ratio.
Based on multivariable Cox proportional hazard model adjusted for age, nationality, educational attainment, marital status, household type, religion, language region,
urbanisation, calendar year, and ICD coding period.
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Discussion
These results provide a comprehensive look at all-cause
and cancer-specific mortality and describe (as never be-
fore) the socio-demographic risk factors specific of older
Swiss adults. In this study, unlike the companion paper,
cancer mortality risk factors did not vary as much as hypo-
thesised across older age-groups. However, for outcomes
and characteristics with age-specific variation the oldest-
old (≥85 years) generally showed lower relative cancer
mortality risk (except for non-Swiss lung cancer risk). In-
terestingly, the risk profile for older men and women was
similar: educational attainment and marital status were re-
lated to gender-age-specific cancer risk. And incongru-
ently, these findings showed moderate cancer-specific re-
gional (language region) mortality relative effects unlike
the gender-age-specific absolute trends of our companion
paper.
Cancer is a disease of aging because it is known to be
a multi-step process, and with longevity there is both in-
creased opportunity for DNA damage and longer exposures
to potential carcinogens [10]. If older adults have greater
potential for accrued molecular damage coexisting with
age-related decreased cellular repair activity; increased
cancer risk should be expected. This and other older-age-
specific population-based epidemiologic evidence (albeit
more limited than all-age) demonstrating greater cancer
burden in older adults support these proposed aging-cancer
linked processes [1, 30–35]. However, as this work indic-
ates in Switzerland (like other developed countries) age
alone is not the only important cancer risk factor and risk is
not necessarily the same across older age-groups.
Table 3: Relative risks for cancer mortality in Swiss women ≥65 years old , 1991–2008.
Cancer mortality – HR (95% CI)Characteristic Category
All-cancer Lung cancer Colorectal cancer Breast cancer
Nationality Swiss
Non-Swiss
1
0.98 (0.95, 1.01)
1
0.92 (0.84, 1.01)
1
1.10 (1.02, 1.20)
1
0.96 (0.89, 1.03)
Educational attainment Compulsory or less
Secondary education
Tertiary education
1.03 (1.02, 1.05)
1
0.95 (0.92, 0.98)
1.05 (1.00, 1.10)
1
0.79 (0.71, 0.88)
0.97 (0.93, 1.01)
1
0.91 (0.83, 1.01)
0.97 (0.93, 1.00)
1
1.03 (0.95, 1.11)
Marital status Single
Married
Widowed
Divorced
1.16 (1.13, 1.19)
1
1.17 (1.14, 1.20)
1.23 (1.19, 1.27)
1.11 (1.02, 1.22)
1
1.32 (1.23, 1.42)
1.84 (1.68, 2.01)
1.08 (1.01, 1.17)
1
1.15 (1.08, 1.22)
1.12 (1.03, 1.23)
1.25 (1.18, 1.33)
1
1.10 (1.05, 1.16)
1.13 (1.04, 1.21)
Household type Single person
Multi-person
Institutions
0.98 (0.96, 1.00)
1
0.98 (0.95, 1.01)
1.07 (1.00, 1.14)
1
0.72 (0.63, 0.82)
1.03 (0.97, 1.09)
1
1.01 (0.94, 1.09)
0.97 (0.93, 1.02)
1
1.28 (1.20, 1.36)
Religion Protestant
Roman Catholic
No denomination
Other / unknown
1
1.03 (1.02, 1.05)
1.08 (1.04, 1.11)
0.94 (0.91, 0.97)
1
1.04 (0.99, 1.09)
1.51 (1.38, 1.64)
1.21 (1.09, 1.33)
1
1.02 (0.98, 1.06)
1.06 (0.97, 1.16)
0.88 (0.80, 0.97)
1
1.02 (0.99, 1.06)
1.09 (1.01, 1.18)
0.93 (0.86, 1.01)
Language region German
French
Italian
1
0.99 (0.98, 1.01)
1.03 (1.00, 1.06)
1
1.29 (1.23, 1.36)
1.29 (1.17, 1.41)
1
1.02 (0.98, 1.06)
0.95 (0.88, 1.04)
1
0.92 (0.89, 0.96)
0.95 (0.88, 1.02)
Urbanisation Urban
Peri-urban
Rural
1
0.98 (0.96, 0.99)
0.95 (0.93, 0.99)
1
0.90 (0.86, 0.95)
0.69 (0.65, 0.73)
1
0.99 (0.95, 1.03)
0.96 (0.92, 1.01)
1
0.97 (0.93, 1.00)
0.96 (0.92, 1.00)
CI = confidence interval; HR = hazard ratio.
Based on multivariable Cox proportional hazard model adjusted for age, nationality, educational attainment, marital status, household type, religion, language region,
urbanisation, calendar year, and ICD coding period.
Table 4: Gender-age-specific relative risks for cancer mortality in older Swiss adults ≥65 years old, 1991–2008.
Males Females
65–74 years 75–84 years ≥85 years 65–74 years 75–84 years ≥85 years
All-cancer All-cancer
Educational attainment ≤Compulsory
Secondary
Tertiary
1.15 (1.13, 1.18)
1
0.77 (0.75, 0.79)
1.08 (1.05, 1.10)
1
0.87 (0.85, 0.90)
1.01 (0.98, 1.04)
1
0.96 (0.92, 1.00)
1.05 (1.03, 1.08)
1
0.94 (0.90, 0.99)
1.02 (1.00, 1.04)
1
0.95 (0.90, 1.00)
1.03 (1.00, 1.06)
1
0.95 (0.87, 1.03)
Marital status Single
Married
Widowed
Divorced
1.08 (1.04, 1.13)
1
1.12 (1.07, 1.18)
1.27 (1.21, 1.32)
0.94 (0.90, 0.98)
1
1.13 (1.09, 1.17)
1.14 (1.08, 1.20)
0.87 (0.82, 0.93)
1
1.07 (1.03, 1.12)
1.00 (0.91, 1.10)
1.20 (1.15, 1.26)
1
1.18 (1.13, 1.23)
1.27 (1.21, 1.34)
1.14 (1.10, 1.19)
1
1.17 (1.13, 1.21)
1.22 (1.16, 1.29)
1.07 (1.02, 1.13)
1
1.11 (1.06, 1.16)
1.09 (1.01, 1.17)
Lung cancer Lung cancer
Nationality Swiss
Non-Swiss
1
1.03 (0.97, 1.09)
1
1.10 (1.01, 1.19)
1
1.27 (1.05, 1.52)
1
0.77 (0.68, 0.87)
1
1.07 (0.92, 1.24)
1
1.30 (1.01, 1.67)
Prostate cancer Breast cancer
Language region German
French
Italian
1
1.01 (0.94, 1.08)
0.84 (0.72, 0.97)
1
1.01 (0.97, 1.06)
0.86 (0.77, 0.95)
1
0.86 (0.81, 0.92)
0.82 (0.72, 0.92)
1
0.84 (0.78, 0.89)
1.02 (0.91, 1.15)
1
0.99 (0.93, 1.05)
0.98 (0.87, 1.10)
1
0.94 (0.87, 1.01)
0.84 (0.72, 0.96)
CI = confidence interval; HR = hazard ratio.
Based on multivariable Cox proportional hazard model adjusted for age, nationality, educational attainment, marital status, household type, religion, language region,
urbanisation, calendar year, and ICD coding period.
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Our findings that relative and absolute (from companion
paper) all-cancer and cancer-specific mortality risk was
inversely related to educational attainment is consistent
with studies from other developed countries evaluating so-
cioeconomic status (SES) and/or education as a proxy for
SES (for example [36–38]). In Switzerland and other deve-
loped countries, persistent differences in cancer mortality
risk across educational gradients and age-groups are both
cause for concern (i.e., pervasiveness of their effect) and
represent a chance to better understand SES-related risk
factors and how they lead to better-or-worse cancer out-
comes. The differences in cancer risk associated with edu-
cation (or SES) likely reflect differences in financial re-
sources, lifestyles (including carcinogenic exposures), and
access to healthcare services that influence cancer mortal-
ity risk. Of interest in these findings are the attenuated ef-
fects of educational attainment in older women as com-
pared with men. We surmise that the true education-cancer-
mortality effect in older women is underestimated. We
know that most Swiss older women were married, had
compulsory or less education, were primarily housewives
not working outside the home (birth cohort effect); but
were often married to men with higher educational at-
tainment [5]. The educational attainment of their spouses
would influence available resources potentially associated
with their cancer mortality risk. Likewise, we see that mar-
ried older persons in this study had generally the lowest
cancer mortality risk also indicating a mutual support sys-
tem that likely includes both instrumental (i.e., resources)
and emotional support components moderating cancer risk.
Future research attempting to disentangle these SES older-
age-specific cancer mortality effects should be conducted.
These findings showed fluctuating (for both older men and
women) all-cancer and cancer-specific relative mortality
effects by language region. Although these may repres-
ent possible cultural differences (i.e., lifestyle, diet, family
support, etc.) they require further consideration given the
lack of difference seen in absolute rates in the companion
paper. In principle, differences in absolute rates that res-
ult in differences in relative risks may have very different
meaning (e.g., 2/100,000 PY and 1/100,000 PY as well as
20,000/100,000 PY and 10,000/100,000 PY give the same
relative risk but do not have the same absolute population
impact). This is further emphasised by modest differen-
ces in SMR but not strictly by language region (e.g., Fri-
bourg, Lausanne, Neuchâtel, Sion, and Geneva all French-
speaking). By considering both absolute and relative cancer
mortality risks in older adults by a broad set of socio-
demographic characteristics this study provides a uniquely
robust population-based epidemiological analysis. This is
noteworthy because cancer is disease of aging that dispro-
portionately affects older adults and often results in consid-
erable consequences not just for aging individuals but sim-
ultaneously for healthcare systems, families, and caregivers
providing for their needs. Socio-demographic age-specific
information exposes opportunities for tailored public health
interventions aimed ultimately at reducing cancer burden in
developed societies. See companion paper for discussion of
smoking and lung cancer mortality risk.
International studies based on EUROCARE data
(European population-based registration data including
limited Swiss cantons) demonstrated that cancer survival
varied by age; European older adults had nearly 60% high-
er relative risk of death compared to younger adults [39].
In addition and more disturbingly, an increasing all-cancer
and cancer-specific survival gap in older adults in Europe
was also observed [40]. Although none of these findings
were evaluated by socio-demographic or other important
age-related factors. Since age is considered the most im-
portant risk factor for cancer and is also associated with in-
creasing comorbidity, co-existing diseases are of substan-
tial concern in older populations [41]. Indeed, cancer pa-
tients 70 years and older have on average three comorbidit-
ies [41, 42]. Comorbidities can drastically impact diagnos-
is, treatment, and/or recovery from cancer. Older cancer
patients are more often diagnosed at later or with unknown
stage, more likely to be undertreated, and receive less dis-
ease information than younger cancer patients [43–47].
Also of concern is that older adults with late stage dia-
gnosis and/or severe multiple comorbidities might be under
counted (due to deaths from comorbidities) and also more
likely to have poor prognosis (unable to tolerate aggressive
therapy). Although our work (and others’) was unable to
evaluate age and stage at diagnosis and comorbidity they
are essential pieces of the cancer story in older adults that
require additional epidemiological research. Population-
based studies that can include other health-related informa-
tion are essential.
This study has strengths and weakness similar to those re-
ported in our companion paper. First, it encompassed a
very large population-based sample of older Swiss adults
permitting with statistical precision generalisability to the
older population in Switzerland. Moreover, it is one of the
few broad investigations of population-based cancer mor-
tality risk that is specific to older adults, includes exact per-
son time with long follow-up (up to 18 years), and explores
gender-age-specific variations across a number of socio-
demographic characteristics. Unfortunately, even though
these analyses were adjusted for many socio-demograph-
ic characteristics we cannot rule out potential confounding
and/or interaction by other unavailable factors (e.g., health,
lifestyle, genetic). Future analyses are planned to include
additional risk factor information to enhance these results
and address at least some of the limitations due to unmeas-
ured variables. Finally, our study was based on probabil-
istic linkage and subject to its associated limitations [48].
Nevertheless, previous evaluations of the SNC have shown
linkage is most successful in adults older than 25 years and
no indication of selection bias [16].
In summary, this comprehensive epidemiological evalu-
ation provides additional needed information about the
aging-cancer nexus in developed countries. These results
can help to identify which groups of Swiss older adults are
at greatest risk for cancer mortality. This can be useful for
cancer control programmes, specifically targeting interven-
tions, healthcare resources, and tracking cancer disparit-
ies over time. Although additional and continually updated
epidemiologic exploration of these factors, their associ-
ations with cancer burden, and their influence on grow-
ing aging populations in Switzerland and other developed
countries is required. Future work with consideration of
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stage of disease, treatments received, and comorbidity are
essential.
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Supplementary tables
Supplementary table 1
Sensitivity analysis results comparing all-cancer mortality risk adjusted and unadjusted for unlinked deaths from 1991 through 2008 in older Swiss adults ≥65 years old.
Characteristic Gender Category HR (95% CI)
unadjusted for unlinked deaths
HR (95% CI)
adjusted for unlinked deaths
Education Males Compulsory or less
Secondary education
Tertiary education
1.17 (1.15, 1.20)
1
0.76 (0.74, 0.78)
1.15 (1.13, 1.18)
1
0.77 (0.75, 0.79)
Females Compulsory or less
Secondary education
Tertiary education
1.06 (1.03, 1.08)
1
0.93 (0.88, 0.98)
1.05 (1.03, 1.08)
1
0.94 (0.90, 0.99)
Nationality Males Swiss
Non-Swiss
1
0.93 (0.90, 0.96)
1
0.97 (0.94, 1.00)
Females Swiss
Non-Swiss
1
0.90 (0.86, 0.94)
1
0.95 (0.90, 0.99)
Marital status Males Single
Married
Widowed
Divorced
1.05 (1.00, 1.09)
1
1.13 (1.07, 1.19)
1.23 (1.18, 1.29)
1.08 (1.04, 1.13)
1
1.12 (1.07, 1.18)
1.27 (1.21, 1.32)
Females Single
Married
Widowed
Divorced
1.18 (1.12, 1.24)
1
1.15 (1.10, 1.20)
1.27 (1.21, 1.33)
1.20 (1.15, 1.26)
1
1.18 (1.13, 1.23)
1.27 (1.21, 1.34)
Language region Males German
French
Italian
1
1.06 (1.04, 1.09)
1.13 (1.08, 1.18)
1
1.08 (1.05, 1.10)
1.14 (1.10, 1.19)
Females German
French
Italian
1
0.95 (0.92, 0.98)
0.99 (0.94, 1.04)
1
0.96 (0.94, 0.99)
1.01 (0.96, 1.06)
CI = confidence interval; HR = hazard ratio.
Based on multivariable Cox proportional hazard model adjusted for age, nationality, educational attainment, marital status, household type, religion, language region,
urbanisation, calendar year, and ICD coding period.
Supplementary table 2
Comparison of all-cancer mortality risk from 1991 through 2008 in older Swiss adults ≥65 years old using Cox proportional hazards and Poisson regression models.
Characteristic Gender Category HR (95% CI)
Cox regression
IRR (95% CI)
Poisson regression
Education Males Compulsory or less
Secondary education
Tertiary education
1.15 (1.13, 1.18)
1
0.77 (0.75, 0.79)
1.16 (1.13, 1.18)
1
0.77 (0.75, 0.79)
Females Compulsory or less
Secondary education
Tertiary education
1.05 (1.03, 1.08)
1
0.94 (0.90, 0.99)
1.05 (1.03, 1.08)
1
0.94 (0.90, 0.99)
Nationality Males Swiss
Non-Swiss
1
0.97 (0.94, 1.00)
1
0.97 (0.94, 1.00)
Females Swiss
Non-Swiss
1
0.95 (0.90, 0.99)
1
0.95 (0.91, 0.99)
Marital status Males Single
Married
Widowed
Divorced
1.08 (1.04, 1.13)
1
1.12 (1.07, 1.18)
1.27 (1.21, 1.32)
1.08 (1.04, 1.13)
1
1.12 (1.07, 1.18)
1.27 (1.21, 1.32)
Females Single
Married
Widowed
Divorced
1.20 (1.15, 1.26)
1
1.18 (1.13, 1.23)
1.27 (1.21, 1.34)
1.20 (1.15, 1.26)
1
1.18 (1.14, 1.23)
1.27 (1.21, 1.34)
Language region Males German
French
Italian
1
1.08 (1.05, 1.10)
1.14 (1.10, 1.19)
1
1.08 (1.05, 1.10)
1.14 (1.10, 1.19)
Females German
French
Italian
1
0.96 (0.94, 0.99)
1.01 (0.96, 1.06)
1
0.96 (0.93, 0.99)
1.01 (0.96, 1.06)
CI = confidence interval; IRR = incidence rate ratio; HR = hazard ratio.
Models adjusted for age, nationality, educational attainment, marital status, language region, religion, household type, urbanisation, calendar year, and ICD coding period.
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Figures (large format)
Figure 1
B Map of Switzerland showing standardised cancer mortality ratios for older Swiss women (≥65 years old).
© BFS. Reprinted with permission.
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